High-dose concurrent chemo–proton therapy for Stage III NSCLC: preliminary results of a Phase II stu...
High-dose concurrent chemo–proton therapy for Stage III NSCLC: preliminary results of a Phase II study
About this item
Full title
Author / Creator
Publisher
England: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
England: Oxford University Press
Subjects
More information
Scope and Contents
Contents
The aim of this report is to present the preliminary results of a Phase II study of high-dose (74 Gy RBE) proton beam therapy (PBT) with concurrent chemotherapy for unresectable locally advanced non-small-cell lung cancer (NSCLC). Patients were treated with PBT and chemotherapy with monthly cisplatin (on Day 1) and vinorelbine (on Days 1 and 8). Th...
Alternative Titles
Full title
High-dose concurrent chemo–proton therapy for Stage III NSCLC: preliminary results of a Phase II study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4202292
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4202292
Other Identifiers
ISSN
0449-3060
E-ISSN
1349-9157
DOI
10.1093/jrr/rru034
